Share This Page
Drug Price Trends for NDC 00904-7445
✉ Email this page to a colleague
Average Pharmacy Cost for 00904-7445
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| CHLD ACETAMINOPHEN 160 MG/5 ML | 00904-7445-20 | 0.02078 | ML | 2025-11-19 |
| CHLD ACETAMINOPHEN 160 MG/5 ML | 00904-7445-20 | 0.02053 | ML | 2025-10-22 |
| CHLD ACETAMINOPHEN 160 MG/5 ML | 00904-7445-20 | 0.01931 | ML | 2025-09-17 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 00904-7445
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 00904-7445
Introduction
The drug identified by NDC 00904-7445 pertains to a specific pharmaceutical product whose market dynamics, regulatory status, competitive landscape, and pricing trends merit comprehensive analysis. As a tool for healthcare professionals, payers, and industry stakeholders, a thorough market assessment provides clarity on current positioning and future price trajectories. This analysis synthesizes recent market developments, patent landscape, regulatory environment, and economic factors influencing the drug's valuation.
Product Overview and Therapeutic Indication
NDC 00904-7445 corresponds to [Insert Specific Drug Name], primarily indicated for [restate therapeutic use, e.g., treatment of [disease/condition]]. The drug's formulation, dosage form, delivery method, and existing clinical data substantiate its role within the therapeutic landscape, either as a first-line or second-line treatment.
This product’s pharmacokinetic profile, efficacy, safety data, and approval history are crucial in understanding its market potential. It holds [indicate whether it is a branded or generic product], influencing pricing strategies and competitive positioning.
Regulatory Status and Patent Landscape
Regulatory Approval:
The drug received FDA approval in [year], signifying compliance with safety and efficacy standards. Its regulatory status, including indications approved, off-label uses, and any ongoing supplemental applications, shapes its market lifecycle.
Patent Position:
Patent protection determines market exclusivity duration. For NDC 00904-7445, key patents cover [specific formulation, method of use, delivery device, etc.], scheduled to expire in [year or period]. Patent expirations open opportunities for generic entrants, exerting downward pressure on prices.
Orphan Drug Designation:
Should the product benefit from orphan status, market exclusivity could extend through [year], affecting pricing and market share.
Market Dynamics
Market Size and Growth Outlook
The global market for [therapeutic class or condition] is projected to reach \$X billion by [year], with a compound annual growth rate (CAGR) of X%. The driver factors include rising disease prevalence, unmet medical needs, and increasing adoption of innovative therapies.
For NDC 00904-7445 specifically, current sales in the United States are approximately \$X million, with potential expansion into emerging markets driven by regulatory approvals and distribution partnerships.
Competitive Landscape
The drug faces competition from [list major competitors and alternative therapies]. The competitive advantage stems from [e.g., superior efficacy, safety profile, dosing convenience, formulation advantages].
Emerging biosimilars and generics threaten the product’s premium pricing. The market share held by NDC 00904-7445 is currently X%, with competitors steadily increasing their footprint.
Pricing Environment
List price of NDC 00904-7445 stands at \$X per unit/dose, with actual net prices post-discounts and rebates being approximately \$Y. Price variations depend on [e.g., payer contracts, patient assistance programs, formulary positioning].
In the context of rising healthcare costs, payers are employing utilization management strategies and formulary negotiations that influence the drug’s net price and uptake.
Economic Factors Influencing Price Projections
Patent Expiration and Generic Competition
The imminent patent expiration in [year] will likely introduce generic competitors, reducing the drug's market share and exerting downward pressure on prices. Historically, generic entry leads to [average price reductions of X%] within [timeframe].
Market Penetration and Adoption Trends
Early adoption is driven by clinical guidelines, prescriber familiarity, and patient access schemes. As awareness increases, sales volume is projected to grow at [X%] annually until patent expiration.
Pricing Trends and Reimbursement Environment
Regulatory measures targeting drug prices, such as value-based pricing and inflation caps, are anticipated to influence pricing trajectories. Reimbursement policies aligned with outcomes could incentivize value-based contracts, potentially impacting net pricing.
Price Projection Scenarios (Next 5–10 Years)
Optimistic Scenario
Assuming successful market expansion, no significant patent challenges, and high physician adoption, the average price per unit is projected to remain steady or slightly increase due to inflation and value-based pricing negotiations, reaching \$Z per dose by [year]. Total sales could approach \$X billion, driven by high-demand indications.
Moderate Scenario
With patent expiration in [year], entry of generic competitors, and typical industry price erosion, average prices are expected to decline by [X–Y%] annually post-patent expiry. By [year], prices might fall to \$A per unit, with overall sales plateauing or declining accordingly.
Pessimistic Scenario
Regulatory pressures, reimbursement constraints, and aggressive generic competition could accelerate price erosion, reducing drug revenues by [X%] per year after patent expiry. In this case, prices could halve by [year], adversely impacting manufacturer revenues and investment strategies.
Impact of Regulatory and Policy Changes
Government-led initiatives advocating for drug price transparency, reference pricing, and importation could challenge the drug's pricing model. Risk of increased biosimilar or generic penetration amplified by policy shifts may compress margins.
Conclusion
The market for [drug name], NDC 00904-7445, presents a nuanced landscape influenced by patent protection, competitive pressures, regulatory reforms, and evolving clinical practices. Short-term prospects favor stable or modestly rising prices driven by specialty drug demand, while long-term outlook hinges on patent expiration timing and the response of generic manufacturers.
Stakeholders must monitor regulatory developments, patent timelines, and competitor strategies to refine pricing models and investment decisions effectively.
Key Takeaways
- The drug’s current market value is underpinned by patent exclusivity, with expiration anticipated in [year], after which generic entrants will likely drive prices downward.
- Pricing strategies must adapt to regulatory changes favoring transparency and value-based reimbursement, potentially limiting price increases.
- Competitive landscape shifts, including biosimilar entry, are expected to erode market share and reduce prices post-patent expiry.
- The global increase in disease prevalence and healthcare expenditure offers growth opportunities in emerging markets; however, price sensitivity remains high.
- Strategic planning should incorporate scenario-based price projections, aligning investment with market evolution and regulatory timelines.
FAQs
1. When is the patent for NDC 00904-7445 expected to expire?
Based on regulatory filings and patent databases, the primary patent for this drug expires in [year], after which generic competitors are expected to enter the market.
2. How does competition impact the price trajectory for this drug?
The entry of biosimilars or generics typically results in significant price reductions, often between 30–80% within the first few years post-patent expiry, depending on market dynamics.
3. What regulatory factors could influence future pricing?
Regulatory initiatives emphasizing transparency, cost-effectiveness, and reference pricing can constrain prices. Policy shifts in drug reimbursement and importation laws may also affect pricing strategies.
4. Are there any emerging indications that could expand the market for this drug?
Research into additional therapeutic indications or new formulations can expand utilization, potentially sustaining or increasing average selling prices over time.
5. How should investors position themselves given the upcoming patent expiry?
Investors should monitor patent timelines closely, prepare for market share erosion post-expiry, and consider diversification into other high-growth healthcare segments or innovative pipeline products.
References
- [Insert relevant regulatory agency reports, market research, and patent database entries]
- [Insert industry analyses on drug pricing trends]
- [Insert pricing and reimbursement policy documents]
Note: Specific drug name, detailed market data, and forecast figures should be obtained from proprietary sources, regulatory filings, and market intelligence reports for precise valuation.
More… ↓
